Payal Kohli Selected Research

Payal Kohli Research Topics

Disease

8	Myocardial Infarction 02/2014 - 01/2012
7	Stroke (Strokes) 11/2016 - 06/2012
5	Cardiovascular Diseases (Cardiovascular Disease) 10/2019 - 12/2012
4	Dyslipidemias (Dyslipidemia) 01/2016 - 01/2012
4	Acute Coronary Syndrome 01/2014 - 01/2012
3	Diabetes Mellitus 11/2016 - 08/2013
3	Insulin Resistance 11/2016 - 11/2013
3	Hemorrhage 02/2016 - 06/2012
3	Ischemia 01/2014 - 01/2012
3	Hypercholesterolemia 08/2013 - 01/2012
2	Type 2 Diabetes Mellitus (MODY) 11/2016 - 10/2016
2	Heart Failure 02/2016 - 01/2014
2	Coronary Disease (Coronary Heart Disease) 01/2016 - 01/2012
2	Thrombosis (Thrombus) 01/2014 - 07/2012
2	Heart Diseases (Heart Disease) 01/2012 - 01/2012
2	Inflammation (Inflammations) 10/2009 - 01/2007
1	Prediabetic State (Prediabetes) 11/2016
1	Coinfection 01/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016
1	Hepatitis C 01/2016
1	Hypertension (High Blood Pressure) 01/2014
1	Ischemic Stroke 01/2014
1	Ventricular Remodeling 01/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2013
1	Peripheral Arterial Disease 09/2013
1	Transient Ischemic Attack 02/2013
1	Body Weight (Weight, Body) 07/2012
1	Atrial Fibrillation 06/2012
1	Cerebral Hemorrhage 06/2012
1	Respiratory Hypersensitivity 01/2007
1	Asthma (Bronchial Asthma) 01/2007
1	Acute Lung Injury 04/2005

Drug/Important Bio-Agent (IBA)

7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2016 - 01/2012
5	LDL CholesterolIBA 01/2016 - 01/2012
5	LipidsIBA 01/2016 - 10/2009
4	Triglycerides (Triacylglycerol)IBA 11/2016 - 01/2012
4	oxidized low density lipoproteinIBA 02/2014 - 01/2012
3	CholesterolIBA 11/2016 - 01/2012
3	evolocumabIBA 02/2014 - 01/2012
3	Monoclonal AntibodiesIBA 02/2014 - 01/2012
3	Pharmaceutical PreparationsIBA 07/2012 - 10/2009
2	Glucose (Dextrose)FDA LinkGeneric 11/2016 - 10/2016
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 01/2012
2	Clopidogrel (Plavix)FDA Link 01/2014 - 02/2013
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2014 - 01/2014
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2014 - 06/2012
2	RivaroxabanIBA 07/2012 - 06/2012
2	Thrombin FDA Link 07/2012 - 06/2012
2	LeukotrienesIBA 10/2009 - 01/2007
1	Insulin (Novolin)FDA Link 10/2016
1	Heparin (Liquaemin)FDA LinkGeneric 02/2016
1	bivalirudin (Angiomax)FDA Link 02/2016
1	SubtilisinIBA 01/2016
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2016
1	Trinitrotoluene (TNT)IBA 01/2016
1	Atorvastatin (Lipitor)FDA Link 01/2016
1	Adenosine Triphosphate (ATP)IBA 02/2014
1	Prasugrel Hydrochloride FDA Link 01/2014
1	CreatinineIBA 01/2014
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2014
1	SaltsIBA 01/2014
1	EnzymesIBA 11/2013
1	HDL CholesterolIBA 11/2013
1	C-Reactive ProteinIBA 11/2013
1	Lipoproteins (Lipoprotein)IBA 09/2013
1	Lipoprotein(a)IBA 08/2013
1	Proprotein Convertase 9IBA 08/2013
1	TicagrelorIBA 02/2013
1	Immunoglobulin G (IgG)IBA 12/2012
1	Factor Xa (Coagulation Factor Xa)IBA 07/2012
1	Factor Xa InhibitorsIBA 06/2012
1	Factor IIaIBA 06/2012
1	apixabanIBA 06/2012
1	Dabigatran FDA Link 06/2012
1	AntithrombinsIBA 06/2012
1	Vitamin K FDA Link 06/2012
1	Warfarin (Coumadin)FDA LinkGeneric 06/2012
1	Neurofibromin 2 (Merlin)IBA 01/2012
1	Ranolazine FDA Link 01/2012
1	ProstaglandinsIBA 10/2009
1	Interleukin-13IBA 01/2007
1	Methacholine Chloride (Methacholine)FDA Link 01/2007
1	Prostaglandins DIBA 01/2007
1	protectin D1IBA 01/2007
1	Docosahexaenoic AcidsIBA 01/2007
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2005

Therapy/Procedure

9	Therapeutics 10/2019 - 04/2005
2	Percutaneous Coronary Intervention 02/2016 - 01/2014
1	Length of Stay 02/2016
1	Secondary Prevention 01/2016
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 02/2013